LAMARCA, ANGELA, PALMER, DANIEL H, WASAN, HARPREET SINGH, ROSS, PAUL J, MA, YUK TING, ARORA, ARVIND, FALK, STEPHEN, GILLMORE, ROOPINDER, WADSLEY, JONATHAN, PATEL, KINNARI and OTHERS, 2023. Significance of alterations in DNA damage repair (DDR) genes in advanced biliary cancers (ABCs) treated with second-line active-symptom-control (ASC) alone or ASC with oxaliplatin/5-FU chemotherapy (ASC+ FOLFOX) in the randomised phase III, multicentre, open-label ABC-06 trial.
MCNAMARA, MAIREAD GERALDINE, TIMMINS, HAYLEY, OSBORNE, ASHLEY, COX, REBECCA, WASAN, HARPREET SINGH, CORRIE, PIPPA, GILLMORE, ROOPINDER, SIVAKUMAR, SHIVAN, MA, YUK TING, FALUYI, OLUSOLA OLUSESAN and OTHERS, 2023. ABC-12: Exploring the microbiome in patients (pts) with advanced biliary tract cancer (BTC) in a first-line study of durvalumab in combination with cisplatin/gemcitabine (cis/gem).
LAMARCA, ANGELA, PALMER, D, WASAN, H, ROSS, P, MA, Y TING, ARORA, A, FALK, S, GILLMORE, R, WADSLEY, J, PATEL, K and OTHERS, 2022. P-88 Clinical role of tumour markers in advanced biliary cancers (ABC) treated with second-line active-symptom-control (ASC) alone or ASC with oxaliplatin/5-FU chemotherapy (ASC+ mFOLFOX) in the randomised phase III, multi-centre, open-label ABC-06 trial Annals of Oncology. 33, S280
ARORA, A, STORR, SJ, REDDY, H, LOBO, DN, MADHUSUDAN, S and ZAITOUN, AM, 2022. O085 CD10 expression in carcinomas of the pancreas, bile duct and ampulla British Journal of Surgery. 109(Supplement_4), znac242-085
LAMARCA, A, PALMER, D, WASAN, HS, ROSS, P, MA, YT, ARORA, A, FALK, S, GILLMORE, R, WADSLEY, J, PATEL, K and OTHERS, 2022. 54MO Quality of life (QoL) and value of health (V-He) in advanced biliary cancers (ABC) treated with second-line active-symptom-control (ASC) alone or ASC with oxaliplatin/5-FU chemotherapy (ASC+ FOLFOX) in the randomised phase III, multi-centre, open-label ABC-06 trial Annals of Oncology. 33, S564-S565
SAVVA, CONSTANTINOS, SADIQ, MAAZ, SHEIKH, OMAR, KARIM, SYED, TRIVEDI, SACHIN, GREEN, ANDREW R, RAKHA, EMAD A, MADHUSUDAN, SRINIVASAN and ARORA, ARVIND, 2021. Werner syndrome protein expression in breast cancer Clinical Breast Cancer. 21(1), 57-73
LAMARCA, ANGELA, PALMER, DANIEL H, WASAN, HARPREET SINGH, ROSS, PAUL J, MA, YUK TING, ARORA, ARVIND, FALK, STEPHEN, GILLMORE, ROOPINDER, WADSLEY, JONATHAN, PATEL, KINNARI and OTHERS, 2021. Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial The Lancet Oncology. 22(5), 690-701
LAMARCA, ANGELA, PALMER, DANIEL H, WASAN, HARPREET SINGH, ROSS, PAUL J, MA, YUK TING, ARORA, ARVIND, FALK, STEPHEN, GILLMORE, ROOPINDER, WADSLEY, JONATHAN, PATEL, KINNARI and OTHERS, 2021. Second-line FOLFOX chemotherapy for advanced biliary tract cancer-Authors' reply The Lancet Oncology. 22(7), e288-e289
GRANT, CLAIRE, ALABABRA, EDWARD, DRURY, DAWN, HIGASHI, YUTARO, CLARKE, CHRISTOPHER, BANNUR, UDAY, KAYE, PHILIP, HAIDER, ASMA, ARORA, ARVIND, RAO, ANKIT and OTHERS, 2021. P360 Pilot introduction of a triage system reduces the workload of the HPB MDT
SADIQ, M, KHAN, S, LOPEZ-ESCOLA, C, ARORA, A, HENNIG, I, ABDALLAH, S and SOOMRO, I, 2020. Experience with osimertinib in second-line treatment of non-small cell lung cancer at Nottingham University Hospitals Lung Cancer. 139, S62
ESCOLA, C LOPEZ, SHEIKH, O, FRANKS, H, MENGOLI, K, KARIM, S, KHAN, S, ARORA, A and HENNIG, I, 2019. Retrospective analysis of immunotherapy prognostic scores in advanced NSCLC at Nottingham University Hospitals (UK) Annals of Oncology. 30, v619
ESCOLA, C LOPEZ, SHEIKH, O, FRANKS, H, MALTON, S, GOSSAGE, L, KHAN, S, ARORA, A and HENNIG, I, 2019. Single-centre retrospective analysis of prognostic scores by the Royal Marsden Hospital (RMH) and the Gustave Roussy Institute (GRIm) in a Nottinghamshire population treated with immunotherapy for advanced non-small cell lung cancer (NSCLC) Lung Cancer. 127, S62-S63
LAMARCA, ANGELA, PALMER, DANIEL H, WASAN, HARPREET SINGH, ROSS, PAUL J, MA, YUK TING, ARORA, ARVIND, FALK, STEPHEN, GILLMORE, ROOPINDER, WADSLEY, JONATHAN, PATEL, KINNARI and OTHERS, 2019. ABC-06 vertical bar a randomised phase III study of active symptom control (ASC) with/without mFOLFOX after progression to cisplatin-gemcitabine chemotherapy for patients with advanced biliary tract cancers
ARORA, ARVIND, 2019. Exploring RECQ Helicase landscape in breast cancer
LAMARCA, ANGELA, PALMER, DANIEL H, WASAN, HARPREET SINGH, ROSS, PAUL J, MA, YUK TING, ARORA, ARVIND, FALK, STEPHEN, GILLMORE, ROOPINDER, WADSLEY, JONATHAN, PATEL, KINNARI and OTHERS, 2019. ABC-06| A randomised phase III, multi-centre, open-label study of active symptom control (ASC) alone or ASC with oxaliplatin/5-FU chemotherapy (ASC+ mFOLFOX) for patients (pts) with locally advanced/metastatic biliary tract cancers (ABC) previously-treated with cisplatin/gemcitabine (CisGem) chemotherapy.
LAMARCA, ANGELA, PALMER, DANIEL, WASAN, HARPREET, ROSS, PAUL J, MA, YUK TING, ARORA, ARVID, FALK, STEPHEN, GILLMORE, ROOPINDER, WADSLEY, JONATHAN, PATEL, KINNARI and OTHERS, 2019. FOLFOX as Second-Line Chemotherapy for Advanced Biliary Tract Cancer
LAMARCA, ANGELA, PALMER, DANIEL H, WASAN, HARPREET SINGH, ROSS, PAUL J, MA, YUK TING, ARORA, ARVIND, FALK, STEPHEN, GILLMORE, ROOPINDER, WADSLEY, JONATHAN, PATEL, KINNARI and OTHERS, 2019. ABC-06 vertical bar a randomised phase III study of active symptom control (ASC) with/without mFOLFOX after progression to cisplatin-gemcitabine chemotherapy for patients with advanced biliary tract cancers
ARORA, ARVIND, 2019. Exploring RECQ Helicase landscape in breast cancer
LAMARCA, ANGELA, PALMER, DANIEL H, WASAN, HARPREET SINGH, ROSS, PAUL J, MA, YUK TING, ARORA, ARVIND, FALK, STEPHEN, GILLMORE, ROOPINDER, WADSLEY, JONATHAN, PATEL, KINNARI and OTHERS, 2019. ABC-06| A randomised phase III, multi-centre, open-label study of active symptom control (ASC) alone or ASC with oxaliplatin/5-FU chemotherapy (ASC+ mFOLFOX) for patients (pts) with locally advanced/metastatic biliary tract cancers (ABC) previously-treated with cisplatin/gemcitabine (CisGem) chemotherapy.
BARONE, GIANCARLO, ARORA, ARVIND, GANESH, ANIL, ABDEL-FATAH, TAREK, MOSELEY, PAUL, ALI, REEM, CHAN, STEPHEN YT, SAVVA, CONSTANTINOS, SCHIAVONE, KRISTINA, CARMELL, NATASHA and OTHERS, 2018. The relationship of CDK18 expression in breast cancer to clinicopathological parameters and therapeutic response Oncotarget. 9(50), 29508
BAYLY, JOANNE, EDWARDS, BETHANY E, PEAT, NICOLA, WARWICK, GEOFFREY, HENNIG, IVO M, ARORA, ARVIND, WILCOCK, ANDREW, HIGGINSON, IRENE J and MADDOCKS, MATTHEW, 2018. Developing an integrated rehabilitation model for thoracic cancer services: views of patients, carers and clinicians Pilot and Feasibility Studies. 4,
BARONE, GIANCARLO, ARORA, ARVIND, GANESH, ANIL, ABDEL-FATAH, TAREK, MOSELEY, PAUL, ALI, REEM, CHAN, STEPHEN YT, SAVVA, CONSTANTINOS, SCHIAVONE, KRISTINA, CARMELL, NATASHA and OTHERS, 2018. The relationship of CDK18 expression in breast cancer to clinicopathological parameters and therapeutic response Oncotarget. 9(50), 29508
BAYLY, JOANNE, EDWARDS, BETHANY M, PEAT, NICOLA, WARWICK, GEOFFREY, HENNIG, IVO M, ARORA, ARVIND, WILCOCK, ANDREW, HIGGINSON, IRENE J and MADDOCKS, MATTHEW, 2018. Developing an integrated rehabilitation model for thoracic cancer services: views of patients, informal carers and clinicians Pilot and Feasibility Studies. 4(1), 1-12
BAYLY, JOANNE, EDWARDS, BETHANY E, PEAT, NICOLA, WARWICK, GEOFFREY, HENNIG, IVO M, ARORA, ARVIND, WILCOCK, ANDREW, HIGGINSON, IRENE J and MADDOCKS, MATTHEW, 2018. Developing an integrated rehabilitation model for thoracic cancer services: views of patients, carers and clinicians Pilot and Feasibility Studies. 4,
ARORA, ARVIND, PARVATHANENI, SWETHA, ALESKANDARANY, MOHAMMED A, AGARWAL, DEVIKA, ALI, REEM, ABDEL-FATAH, TAREK, GREEN, ANDREW R, BALL, GRAHAM R, RAKHA, EMAD A, ELLIS, IAN O and OTHERS, 2017. Clinicopathological and Functional Significance of RECQL1 Helicase in Sporadic Breast CancersRECQL1 in Sporadic Breast Cancers Molecular cancer therapeutics. 16(1), 239-250
ARORA, ARVIND, PARVATHANENI, SWETHA, ALESKANDARANY, MOHAMMED A, AGARWAL, DEVIKA, ALI, REEM, ABDEL-FATAH, TAREK, GREEN, ANDREW R, BALL, GRAHAM R, RAKHA, EMAD A, ELLIS, IAN O and OTHERS, 2017. Clinicopathological and Functional Significance of RECQL1 Helicase in Sporadic Breast CancersRECQL1 in Sporadic Breast Cancers Molecular cancer therapeutics. 16(1), 239-250
MO D, FANG H, NIU K, LIU J, WU M, LI S, ZHU T, ALESKANDARANY MA, ARORA A, LOBO DN, MADHUSUDAN S, BALAJEE AS, CHI Z, ZHAO Y, 2016. Human Helicase RECQL4 Drives Cisplatin Resistance in Gastric Cancer by Activating an AKT-YB1-MDR1 Signaling Pathway. Cancer Research. 15(76), 10 ARORA, ARVIND, AGARWAL, DEVIKA, ABDEL-FATAH, TAREK M. A., LU, HUIMING, CROTEAU, DEBORAH L., MOSELEY, PAUL, ALESKANDARANY, MOHAMMED A., GREEN, ANDREW R., BALL, GRAHAM, RAKHA, EMAD A., CHAN, STEPHEN Y. T., ELLIS, IAN O., WANG, LISA L., ZHAO, YONGLIANG, BALAJEE, ADAYABALAM S., BOHR, VILHELM A. and MADHUSUDAN, SRINIVASAN, 2016. RECQL4 helicase has oncogenic potential in sporadic breast cancers JOURNAL OF PATHOLOGY. 238(4), 495-501 ARORA, ARVIND, ABDEL-FATAH, TAREK M. A., AGARWAL, DEVIKA, DOHERTY, RACHEL, CROTEAU, DEBORAH L., MOSELEY, PAUL M., HAMEED, KHALID, GREEN, ANDREW, ALESKANDARANY, MOHAMMED A., RAKHA, EMAD A., PATTERSON, KARL, BALL, GRAHAM, CHAN, STEPHEN Y. T., ELLIS, IAN O., BOHR, VILHELM A., BRYANT, HELEN E. and MADHUSUDAN, SRINIVASAN, 2016. Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers CARCINOGENESIS. 37(1), 63-71 MO, D., FANG, H., NIU, K., LIU, J., WU, M., LI, S., ZHU, T., ALESKANDARANY, M.A., ARORA, A., LOBO, D.N., MADHUSUDAN, S., BALAJEE, A.S., CHI, Z. and ZHAO, Y., 2016. Human helicase RECQL4 drives cisplatin resistance in gastric cancer by activating an AKT-YB1-MDR1 signaling pathway Cancer Research. 76(10), 3057-3066 MO D, FANG H, NIU K, LIU J, WU M, LI S, ZHU T, ALESKANDARANY MA, ARORA A, LOBO DN, MADHUSUDAN S, BALAJEE AS, CHI Z and ZHAO Y, 2016. Human Helicase RECQL4 Drives Cisplatin Resistance in Gastric Cancer by Activating an AKT-YB1-MDR1 Signaling Pathway. Cancer research. 76(10), 3057-66 MO, D., FANG, H., NIU, K., LIU, J., WU, M., LI, S., ZHU, T., ALESKANDARANY, M.A., ARORA, A., LOBO, D.N., MADHUSUDAN, S., BALAJEE, A.S., CHI, Z. and ZHAO, Y., 2016. Human helicase RECQL4 drives cisplatin resistance in gastric cancer by activating an AKT-YB1-MDR1 signaling pathway Cancer Research. 76(10), 3057-3066 MO, D., FANG, H., NIU, K., LIU, J., WU, M., LI, S., ZHU, T., ALESKANDARANY, M.A., ARORA, A., LOBO, D.N., MADHUSUDAN, S., BALAJEE, A.S., CHI, Z. and ZHAO, Y., 2016. Human helicase RECQL4 drives cisplatin resistance in gastric cancer by activating an AKT-YB1-MDR1 signaling pathway Cancer Research. 76(10), 3057-3066 ARORA, A., ABDEL-FATAH, T. M., AGARWAL, D., DOHERTY, R., CROTEAU, D. L., MOSELEY, P. M., HAMEED, K., GREEN, A., ALESKANDARANY, M. A., RAKHA, E. A., PATTERSON, K., BALL, G., CHAN, S. Y., ELLIS, I. O., BOHR, V. A., BRYANT, H. E. and MADHUSUDAN, S., 2016. Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers Carcinogenesis. 37(1), 63-71 MO, D., FANG, H., NIU, K., LIU, J., WU, M., LI, S., ZHU, T., ALESKANDARANY, M. A., ARORA, A., LOBO, D. N., MADHUSUDAN, S., BALAJEE, A. S., CHI, Z. and ZHAO, Y., 2016. Human Helicase RECQL4 Drives Cisplatin Resistance in Gastric Cancer by Activating an AKT-YB1-MDR1 Signaling Pathway Cancer Res. 76(10), 3057-66 ARORA, ARVIND, AGARWAL, DEVIKA, ABDEL-FATAH, TAREK MA, LU, HUIMING, CROTEAU, DEBORAH L, MOSELEY, PAUL, ALESKANDARANY, MOHAMMED A, GREEN, ANDREW R, BALL, GRAHAM, RAKHA, EMAD A and OTHERS, 2016. RECQL4 helicase has oncogenic potential in sporadic breast cancers The Journal of pathology. 238(4), 495-501
MO, DONGLIANG, FANG, HONGBO, NIU, KAIFENG, LIU, JING, WU, MENG, LI, SHIYOU, ZHU, TIENIAN, ALESKANDARANY, MOHAMMED A, ARORA, ARVIND, LOBO, DILEEP N and OTHERS, 2016. Human helicase RECQL4 drives cisplatin resistance in gastric cancer by activating an AKT-YB1-MDR1 signaling pathway Cancer Research. 76(10), 3057-3066
ALSUBHI, NOUF, MIDDLETON, FIONA, ABDEL-FATAH, TAREK MA, STEPHENS, PETER, DOHERTY, RACHEL, ARORA, ARVIND, MOSELEY, PAUL M, CHAN, STEPHEN YT, ALESKANDARANY, MOHAMMED A, GREEN, ANDREW R and OTHERS, 2016. Chk1 phosphorylated at serine345 is a predictor of early local recurrence and radio-resistance in breast cancer Molecular Oncology. 10(2), 213-223
ARORA, ARVIND, ABDEL-FATAH, TAREK MA, AGARWAL, DEVIKA, DOHERTY, RACHEL, CROTEAU, DEBORAH L, MOSELEY, PAUL M, HAMEED, KHALID, GREEN, ANDREW, ALESKANDARANY, MOHAMMED A, RAKHA, EMAD A and OTHERS, 2016. Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers Carcinogenesis. 37(1), 63-71
SHAMANNA, RAGHAVENDRA A, LU, HUIMING, CROTEAU, DEBORAH L, ARORA, ARVIND, AGARWAL, DEVIKA, BALL, GRAHAM, ALESKANDARANY, MOHAMMED A, ELLIS, IAN O, POMMIER, YVES, MADHUSUDAN, SRINIVASAN and OTHERS, 2016. Camptothecin targets WRN protein: mechanism and relevance in clinical breast cancer Oncotarget. 7(12),
MO, DONGLIANG, FANG, HONGBO, NIU, KAIFENG, LIU, JING, WU, MENG, LI, SHIYOU, ZHU, TIENIAN, ALESKANDARANY, MOHAMMED A, ARORA, ARVIND, LOBO, DILEEP N and OTHERS, 2016. Human helicase RECQL4 drives cisplatin resistance in gastric cancer by activating an AKT-YB1-MDR1 signaling pathway Cancer Research. 76(10), 3057-3066
ARORA, ARVIND, ABDEL-FATAH, TAREK MA, AGARWAL, DEVIKA, DOHERTY, RACHEL, CROTEAU, DEBORAH L, MOSELEY, PAUL M, HAMEED, KHALID, GREEN, ANDREW, ALESKANDARANY, MOHAMMED A, RAKHA, EMAD A and OTHERS, 2016. Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers Carcinogenesis. 37(1), 63-71
ALBARAKATI, NADA, ABDEL-FATAH, TAREK M. A., DOHERTY, RACHEL, RUSSELL, ROSLIN, AGARWAL, DEVIKA, MOSELEY, PAUL, PERRY, CHRISTINA, ARORA, ARVIND, ALSUBHI, NOUF, SEEDHOUSE, CLAIRE, RAKHA, EMAD A., GREEN, ANDREW, BALL, GRAHAM, CHAN, STEPHEN, CALDAS, CARLOS, ELLIS, IAN O. and MADHUSUDAN, SRINIVASAN, 2015. Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapy MOLECULAR ONCOLOGY. 9(1), 204-217 ELEFTHERIOU, MARIA, PASCUAL, ANA JIMENEZ, WHELDON, LEE M., PERRY, CHRISTINA, ABAKIR, ABDULKADIR, ARORA, ARVIND, JOHNSON, ANDREW D., AUER, DOROTHEE T., ELLIS, IAN O., MADHUSUDAN, SRINIVASAN and RUZOV, ALEXEY, 2015. 5-Carboxylcytosine levels are elevated in human breast cancers and gliomas CLINICAL EPIGENETICS. 7, ARORA, ARVIND, ABDEL-FATAH, TAREK M. A., AGARWAL, DEVIKA, DOHERTY, RACHEL, MOSELEY, PAUL M., ALESKANDARANY, MOHAMMED A., GREEN, ANDREW R., BALL, GRAHAM, ALSHAREEDA, ALAA T., RAKHA, EMAD A., CHAN, STEPHEN Y. T., ELLIS, IAN O. and MADHUSUDAN, SRINIVASAN, 2015. Transcriptomic and Protein Expression Analysis Reveals Clinicopathological Significance of Bloom Syndrome Helicase (BLM) in Breast Cancer MOLECULAR CANCER THERAPEUTICS. 14(4), 1057-1065 ABDEL-FATAH, TAREK M. A., ARORA, ARVIND, MOSELEY, PAUL M., PERRY, CHRISTINA, RAKHA, EMAD A., GREEN, ANDREW R., CHAN, STEPHEN Y. T., ELLIS, IAN O. and MADHUSUDAN, SRINIVASAN, 2015. DNA repair prognostic index modelling reveals an essential role for base excision repair in influencing clinical outcomes in ER negative and triple negative breast cancers ONCOTARGET. 6(26), 21964-21978
ARORA A, ABDEL-FATAH TM, AGARWAL D, DOHERTY R, CROTEAU DL, MOSELEY PM, HAMEED K, GREEN A, ALESKANDARANY MA, RAKHA EA, PATTERSON K, BALL G, CHAN SY, ELLIS IO, BOHR VA, BRYANT HE and MADHUSUDAN S, 2015. Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers. Carcinogenesis. 37(1), 63-71 SOOD, ANKITA, JINDAL, VARUN, CHHABRA, AJAY, ARORA, ARVIND and VATS, ANKUR, 2015. Comparison of apical transportation, centering ability and cyclic fatigue resistance of four rotary file systems Dental Journal of Advance Studies. 3(01), 012-019
ARORA, ARVIND, ABDEL-FATAH, TAREK MA, AGARWAL, DEVIKA, DOHERTY, RACHEL, MOSELEY, PAUL M, ALESKANDARANY, MOHAMMED A, GREEN, ANDREW R, BALL, GRAHAM, ALSHAREEDA, ALAA T, RAKHA, EMAD A and OTHERS, 2015. Transcriptomic and protein expression analysis reveals clinicopathological significance of bloom syndrome helicase (BLM) in breast cancer Molecular cancer therapeutics. 14(4), 1057-1065
ABDEL-FATAH, TAREK MA, ARORA, ARVIND, MOSELEY, PAUL M, PERRY, CHRISTINA, RAKHA, EMAD A, GREEN, ANDREW R, CHAN, STEPHEN YT, ELLIS, IAN O and MADHUSUDAN, SRINIVASAN, 2015. DNA repair prognostic index modelling reveals an essential role for base excision repair in influencing clinical outcomes in ER negative and triple negative breast cancers Oncotarget. 6(26), 21964
ABDEL-FATAH, TAREK MA, MIDDLETON, FIONA K, ARORA, ARVIND, AGARWAL, DEVIKA, CHEN, TAO, MOSELEY, PAUL M, PERRY, CHRISTINA, DOHERTY, RACHEL, CHAN, STEPHEN, GREEN, ANDREW R and OTHERS, 2015. Untangling the ATR-CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer Molecular oncology. 9(3), 569-585
ELEFTHERIOU, MARIA, PASCUAL, ANA JIMENEZ, WHELDON, LEE M, PERRY, CHRISTINA, ABAKIR, ABDULKADIR, ARORA, ARVIND, JOHNSON, ANDREW D, AUER, DOROTHEE T, ELLIS, IAN O, MADHUSUDAN, SRINIVASAN and OTHERS, 2015. 5-Carboxylcytosine levels are elevated in human breast cancers and gliomas Clinical epigenetics. 7(1), 1-6
ALBARAKATI, NADA, ABDEL-FATAH, TAREK MA, DOHERTY, RACHEL, RUSSELL, ROSLIN, AGARWAL, DEVIKA, MOSELEY, PAUL, PERRY, CHRISTINA, ARORA, ARVIND, ALSUBHI, NOUF, SEEDHOUSE, CLAIRE and OTHERS, 2015. Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapy Molecular oncology. 9(1), 204-217
ABDEL-FATAH, TAREK, ARORA, ARVIND, AGARWAL, DEVIKA, MOSELEY, PAUL, PERRY, CHRISTINA, THOMPSON, NICOLA, GREEN, ANDREW R, RAKHA, EMAD, CHAN, STEPHEN, BALL, GRAHAM and OTHERS, 2014. Adverse prognostic and predictive significance of low DNA-dependent protein kinase catalytic subunit (DNA-PKcs) expression in early-stage breast cancers Breast cancer research and treatment. 146, 309-320
ABDEL-FATAH, TAREK MA, ARORA, ARVIND, MOSELEY, PAUL, COVENEY, CLARE, PERRY, CHRISTINA, JOHNSON, KERSTIE, KENT, CHRISTOPHER, BALL, GRAHAM, CHAN, STEPHEN and MADHUSUDAN, SRINIVASAN, 2014. ATM, ATR and DNA-PKcs expressions correlate to adverse clinical outcomes in epithelial ovarian cancers BBA clinical. 2, 10-17
ABDEL-FATAH, TAREK MA, PERRY, CHRISTINA, MOSELEY, PAUL, JOHNSON, KERSTIE, ARORA, ARVIND, CHAN, STEPHEN, ELLIS, IAN O and MADHUSUDAN, SRINIVASAN, 2014. Clinicopathological significance of human apurinic/apyrimidinic endonuclease 1 (APE1) expression in oestrogen-receptor-positive breast cancer Breast cancer research and treatment. 143, 411-421
ABDEL-FATAH, TAREK MA, PERRY, CHRISTINA, ARORA, ARVIND, THOMPSON, NICOLA, DOHERTY, RACHEL, MOSELEY, PAUL M, GREEN, ANDREW R, CHAN, STEPHEN YT, ELLIS, IAN O and MADHUSUDAN, SRINIVASAN, 2014. Is there a role for base excision repair in estrogen/estrogen receptor-driven breast cancers?
ABDEL-FATAH, TAREK MA, ARORA, ARVIND, ALSUBHI, NOUF, AGARWAL, DEVIKA, MOSELEY, PAUL M, PERRY, CHRISTINA, DOHERTY, RACHEL, CHAN, STEPHEN YT, GREEN, ANDREW R, RAKHA, EMAD and OTHERS, 2014. Clinicopathological significance of ATM-Chk2 expression in sporadic breast cancers: a comprehensive analysis in large cohorts Neoplasia. 16(11), 982-991
ZAITOUN, A, STORR, S, MADHUSUDAN, S, LOBO, D and ARORA, A, 2014. CD10 expression in carcinomas of the pancreas, bile duct and ampulla In: VIRCHOWS ARCHIV. S301-S302
TEWARI, N, ZAITOUN, AM, ARORA, A, MADHUSUDAN, S, ILYAS, M and LOBO, DN, 2013. Prognostic implications of tumour-associated lymphocytes in pancreatic ductal adenocarcinoma and extrahepatic cholangiocarcinoma In: BRITISH JOURNAL OF SURGERY. 21-21
TEWARI, NILANJANA, ZAITOUN, ABED M, ARORA, ARVIND, MADHUSUDAN, SRINIVASAN, ILYAS, MOHAMMAD and LOBO, DILEEP N, 2013. The presence of tumour-associated lymphocytes confers a good prognosis in pancreatic ductal adenocarcinoma: an immunohistochemical study of tissue microarrays BMC cancer. 13(1), 1-10
ABDEL-FATAH, TAREK, ARORA, ARVIND, GORGUC, IPEK, ABBOTTS, RACHEL, BEEBEEJAUN, SARAH, STORR, SARAH, MOHAN, VIVEK, HAWKES, CLAIRE, SOOMRO, IRSHAD, LOBO, DILEEP N and OTHERS, 2013. Are DNA repair factors promising biomarkers for personalized therapy in gastric cancer?
FAREED, KHALEEL R., SOOMRO, IRSHAD N., HAMEED, KHALID, ARORA, ARVIND, LOBO, DILEEP N., PARSONS, SIMON L. and MADHUSUDAN, SRINIVASAN, 2012. Caspase-cleaved cytokeratin-18 and tumour regression in gastro-oesophageal adenocarcinomas treated with neoadjuvant chemotherapy WORLD JOURNAL OF GASTROENTEROLOGY. 18(16), 1915-1920
STORR, SARAH J, ZAITOUN, ABED M, ARORA, ARVIND, DURRANT, LINDY G, LOBO, DILEEP N, MADHUSUDAN, SRINIVASAN and MARTIN, STEWART G, 2012. Calpain system protein expression in carcinomas of the pancreas, bile duct and ampulla BMC cancer. 12, 1-9
ARORA, ARVIND, ABDEL-FATAH, TAREK MA, MOSELEY, PAUL M, AGARWAL, DEVIKA, PERRY, CHRISTINA, DOHERTY, RACHEL, CHAN, STEPHEN, GREEN, ANDREW R, RAKHA, EMAD, ELLIS, IAN O and OTHERS, Prognostic and predictive significance of ATR-Chk1 and ATM-Chk2 network in breast cancers
ARORA, ARVIND, AGARWAL, DEVIKA, LU, HUIMING, CROTEAU, DEBORAH L, ALESKANDARANY, MOHAMMED A, ABDEL-FATAH, TAREK MA, WANG, LISA L, BOHR, VILHELM and MADHUSUDAN, SRINIVASAN, RECQL4 helicase is a key prognostic, predictive and therapeutic target in breast cancer.